Revvity's (RVTY) New Launch to Boost Newborn Sequencing Research
Revvity(RVTY) Zacks Investment Research·2024-03-19 00:36
Revvity, Inc. (RVTY) recently announced the introduction of a flexible end-to-end workflow solution for newborn research. This will likely enable the users to utilize different instruments, reagents and databases based on a lab’s requirements.The research-use-only offering includes dried blood spot collection and processing devices, Chemagic kits and instruments for nucleic acid extraction, liquid handlers and reagents for library preparation, VICTOR2 D Instrument for sample quality control and software cap ...